Today’s Russian Clinical Trials Environment
Along with a growing market economy, Russia’s large treatment-naïve patient population, specialized health care centers and highly skilled clinical research staff have created a favorable environment for outsourcing clinical research. Although the regulatory environment is still improving, the single translation requirement, simplifies regulatory approval to some extent. However, language and cultural barriers remain.